Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-16-012257
Filing Date
2016-04-05
Accepted
2016-04-05 17:13:00
Documents
1
Period of Report
2016-04-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3040416a1luttrell_immucell.html 3/A  
1 OWNERSHIP DOCUMENT f3040416a1luttrell_immucell.xml 3/A 2692
  Complete submission text file 0001213900-16-012257.txt   4073
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O IMMUCELL CORPORATION 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
Williams Elizabeth Luttrell (Reporting) CIK: 0001671164 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-12934 | Film No.: 161555456